2022
Insomnia and Other Sleep Disorders in Older Adults
Cohen Z, Eigenberger P, Sharkey K, Conroy M, Wilkins K. Insomnia and Other Sleep Disorders in Older Adults. Psychiatric Clinics Of North America 2022, 45: 717-734. PMID: 36396275, DOI: 10.1016/j.psc.2022.07.002.Peer-Reviewed Original Research
2021
Emergent and Non-Emergent Agitation in the Older Adult: Evaluation and Management
Subramanian S, Fahed M, Dix E, Wilkins K. Emergent and Non-Emergent Agitation in the Older Adult: Evaluation and Management. Current Geriatrics Reports 2021, 10: 73-81. DOI: 10.1007/s13670-021-00358-6.Peer-Reviewed Original ResearchCohen-Mansfield Agitation InventoryElectroconvulsive therapyOlder adultsPsychiatric disordersNon-pharmacological managementAlcohol withdrawalDistressing symptomsBenzodiazepine usePharmacological treatmentTreatment optionsExcited catatoniaHeterogenous presentationSuccessful treatmentSignificant disabilitySubstance intoxicationNeuropsychiatric conditionsMotor behaviorCognitive enhancersPolypharmacyAdultsDeliriumPatientsCatatoniaReviewThis paperTreatment
2018
Treatment Approaches to Sexual Dysfunction in Late Life
Maruca-Sullivan P, Kleinfeld S, Wilkins K. Treatment Approaches to Sexual Dysfunction in Late Life. Current Treatment Options In Psychiatry 2018, 5: 255-274. DOI: 10.1007/s40501-018-0147-z.Peer-Reviewed Original ResearchSexual dysfunctionPsychotropic medicationsMedication-induced sexual dysfunctionSexual behaviorLatest treatment optionsNon-pharmacologic treatmentsNon-pharmacological optionsFemale sexual disordersAvailable pharmacologicErectile dysfunctionTreatment optionsSexual functionPsychiatric illnessDysfunctionSexual healthSexual disordersMost disordersBehavioral interventionsMultiple treatmentsLater lifeRecent FindingsResearchMedicationsTreatmentDisordersDSM-5
2017
Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions
Hassell C, Wilkins K, Trevisan L. Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions. Current Treatment Options In Psychiatry 2017, 4: 102-115. DOI: 10.1007/s40501-017-0107-z.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSubstance use disordersEvidence-based treatmentsUse disordersGeriatric populationEvidence-based pharmacological treatment optionsAvailable evidence-based treatmentsHigh-quality clinical trialsOlder adultsAvailable pharmacological treatmentsPharmacological treatment optionsLimitations of treatmentPharmacological treatmentTreatment optionsClinical trialsCertain drugsYoung adultsAdverse effectsDisordersTreatmentAdultsHigh rateUnique needsPopulationBaby boomer generationDysfunction